Metformin may slow these processes and improve healthspan by reducing hyperinsulinemia and improving peripheral tissue insulin sensitivity (Martin-Montalvo et al., 2013; Bannister et al., 2014). The gene discussed is INS; the disease is hyperinsulinism.